Recipharm gets new equipment with manufacturing contract; Scil Proteins opens California office;

> Recipharm, a Swedish contract development and manufacturing organization (CDMO), has been hired by ViroPharma of Exton, PA. ViroPharma is investing in equipment for Recipharm to do commercial-scale manufacturing of the modified-release hydrocortisone drug Plenadren. Recipharm release

> Halle, Germany-based Scil Proteins, which does protein production, has opened offices in California to serve its North American contract manufacturing clients. Scil release

​And Finally... Masimo ($MASI), which makes products for the biopharmaceutical industry, has recently acquired assets of Spire Semiconductor, which manufactures component-level items and light-emitting diodes, some of which are used in medical devices. Story

 

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.